The kit is designed to detect polymorphisms associated with drug resistance to second-line chemotherapy drugs (aminoglycosides and fluoroquinolones) and their analogues. The result of the assay makes it possible to choose the appropriate therapy for patients with a confirmed diagnosis of pulmonary and extrapulmonary tuberculosis.
The kit is designed for detection of the tuberculosis and non-tuberculosis complex mycobacteria and their differentiation in patients with suspected pulmonary and extrapulmonary tuberculosis, mycobacteriosis.
The kit is designed for qualitative and quantitative detection of human herpes simplex virus type 6 (HHV-6) DNA. It is used when examining patients with suspected herpes simplex virus infection and a confirmed diagnosis to assess viral load and evaluate the effectiveness of treatment.
The kit is designed for detection and differentiation of human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2) in order to diagnose the HIV infection and choose an antiretroviral therapy regimen.
The kit is designed for detection of the hepatitis C virus and its genotypes (1a,1b, 2, 3, 4, 5a, 6) in patients with the detected virus to choose an appropriate antiviral therapy, to predict and evaluate the course of the disease and possible complications.
The kit is designed for quantitative detection of the hepatitis C virus RNA in patients with suspected infection and patients with the detected hepatitis C virus in order to choose an appropriate therapy and evaluate its effectiveness.